Narasimhan Ragavan

1.2k total citations
48 papers, 945 citations indexed

About

Narasimhan Ragavan is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Rheumatology. According to data from OpenAlex, Narasimhan Ragavan has authored 48 papers receiving a total of 945 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Pulmonary and Respiratory Medicine, 22 papers in Surgery and 7 papers in Rheumatology. Recurrent topics in Narasimhan Ragavan's work include Prostate Cancer Diagnosis and Treatment (19 papers), Prostate Cancer Treatment and Research (15 papers) and Bladder and Urothelial Cancer Treatments (7 papers). Narasimhan Ragavan is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (19 papers), Prostate Cancer Treatment and Research (15 papers) and Bladder and Urothelial Cancer Treatments (7 papers). Narasimhan Ragavan collaborates with scholars based in India, United Kingdom and Germany. Narasimhan Ragavan's co-authors include Francis L. Martin, Shyam S. Matanhelia, Matthew J. German, Hubert M. Pollock, C. Nicholson, Vijay Sangar, Tom Fearn, Paras B. Singh, Ernst C. Wit and Andrew Hindley and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Narasimhan Ragavan

41 papers receiving 928 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Narasimhan Ragavan India 14 313 278 269 191 158 48 945
Michel Pétein Belgium 20 240 0.8× 266 1.0× 373 1.4× 18 0.1× 172 1.1× 77 1.7k
Yanfeng Zhao China 15 108 0.3× 111 0.4× 356 1.3× 47 0.2× 22 0.1× 32 763
Chung‐Hsin Chen Taiwan 21 266 0.8× 593 2.1× 455 1.7× 4 0.0× 189 1.2× 90 2.0k
Vladimír Študent Czechia 17 236 0.8× 251 0.9× 273 1.0× 9 0.0× 9 0.1× 69 909
Qing Zhong China 19 149 0.5× 79 0.3× 503 1.9× 60 0.3× 5 0.0× 77 970
J Petrtýl Czechia 15 143 0.5× 176 0.6× 98 0.4× 41 0.2× 30 0.2× 51 639
Jong-Jae Park South Korea 20 269 0.9× 405 1.5× 181 0.7× 25 0.1× 30 0.2× 56 997
W Jaroß Germany 19 87 0.3× 648 2.3× 293 1.1× 26 0.1× 18 0.1× 73 1.3k
Fangfang Chen China 14 105 0.3× 106 0.4× 207 0.8× 25 0.1× 26 0.2× 40 736
Anastasios G. Kriebardis Greece 26 579 1.8× 129 0.5× 681 2.5× 26 0.1× 3 0.0× 96 2.4k

Countries citing papers authored by Narasimhan Ragavan

Since Specialization
Citations

This map shows the geographic impact of Narasimhan Ragavan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Narasimhan Ragavan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Narasimhan Ragavan more than expected).

Fields of papers citing papers by Narasimhan Ragavan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Narasimhan Ragavan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Narasimhan Ragavan. The network helps show where Narasimhan Ragavan may publish in the future.

Co-authorship network of co-authors of Narasimhan Ragavan

This figure shows the co-authorship network connecting the top 25 collaborators of Narasimhan Ragavan. A scholar is included among the top collaborators of Narasimhan Ragavan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Narasimhan Ragavan. Narasimhan Ragavan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Merseburger, Axel S., Ganesh Bakshi, Dong‐Yi Chen, et al.. (2024). Cardiovascular disease risk assessment and multidisciplinary care in prostate cancer treatment with ADT: recommendations from the APMA PCCV expert network. World Journal of Urology. 42(1). 156–156. 2 indexed citations
3.
Ragavan, Meera Vimala, et al.. (2024). Use of the Medtronic Hugo Robot-Assisted Surgery (RAS) System in Urogynecology: A Safety and Feasibility Study of the First 100 Procedures. Cureus. 16(10). e72213–e72213. 2 indexed citations
4.
Ragavan, Narasimhan, et al.. (2022). Robot-Assisted Laparoscopic Radical Prostatectomy Utilizing Hugo RAS Platform: Initial Experience. Journal of Endourology. 37(2). 147–150. 52 indexed citations
5.
Ragavan, Narasimhan, et al.. (2022). Evaluation of Hugo RAS System in Major Urologic Surgery: Our Initial Experience. Journal of Endourology. 36(8). 1029–1035. 57 indexed citations
6.
Prakash, Jai, Balaji Venugopal, Ananthakrishnan Sivaraman, et al.. (2022). Influence of tumor size in the progression of venous tumor thrombus in renal cell carcinoma. Urology Annals. 14(3). 273–278. 3 indexed citations
7.
Ragavan, Narasimhan, et al.. (2021). The Chennai port closure method: A novel simple technique for laparoscopic port closure. Surgery Open Science. 4. 37–40. 3 indexed citations
8.
Ragavan, Narasimhan, et al.. (2021). Prevalence of Vitamin D Inadequacy in Urolithiasis Patients. Cureus. 13(6). e15379–e15379. 1 indexed citations
9.
Ragavan, Narasimhan, et al.. (2020). Day-case robot-assisted laparoscopic surgery: Feasibility and safety. SHILAP Revista de lepidopterología. 47(1). 30–34. 6 indexed citations
10.
Ragavan, Narasimhan, et al.. (2020). Robot Assisted Laparoscopic Adrenalectomy: Does Size Matter?. Cureus. 12(8). e9887–e9887. 8 indexed citations
11.
Ragavan, Narasimhan, et al.. (2017). Primary intrarenal yolk sac tumor. Indian Journal of Urology. 33(2). 167–167. 5 indexed citations
12.
Shah, Priyank, et al.. (2017). Case report: Robot-assisted laparoscopic excision of giant ganglioneuroma of the adrenal gland. Journal of Robotic Surgery. 12(3). 553–555. 4 indexed citations
13.
Ragavan, Narasimhan. (2014). Prostate biopsy for elevated prostate specific antigen (PSA) - Indian perspective. SHILAP Revista de lepidopterología. 1 indexed citations
14.
Thomsen, Martin K., Laurence Ambroisine, Sarah Wynn, et al.. (2010). SOX9 Elevation in the Prostate Promotes Proliferation and Cooperates with PTEN Loss to Drive Tumor Formation. Cancer Research. 70(3). 979–987. 114 indexed citations
15.
Martin, Francis L., Imran I. Patel, Osman Sözeri, et al.. (2010). Constitutive expression of bioactivating enzymes in normal human prostate suggests a capability to activate pro‐carcinogens to DNA‐damaging metabolites. The Prostate. 70(14). 1586–1599. 29 indexed citations
18.
Ragavan, Narasimhan, et al.. (2005). Is DRE essential for the follow up of prostate cancer patients? A prospective audit of 194 patients. BMC Urology. 5(1). 1–1. 6 indexed citations
19.
Morris, Jonathan D.H., R. Pramanik, Xiangyu Zhang, et al.. (2005). Selenium- or quercetin-induced retardation of DNA synthesis in primary prostate cells occurs in the presence of a concomitant reduction in androgen-receptor activity. Cancer Letters. 239(1). 111–122. 33 indexed citations
20.
Philip, Joe, et al.. (2004). Effect of peripheral biopsies in maximising early prostate cancer detection in 8‐, 10‐ or 12‐core biopsy regimens. British Journal of Urology. 93(9). 1218–1220. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026